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Abstract 33 
Background: The shuttle walking test (SWT) is a simple, widely used method for 34 
assessing endurance performance in the elderly. Despite widespread community use, its 35 
associated factors are unclear.  36 
Aims: We aim to identify previously undefined SWT association factors in 37 
community-dwelling elderly people. 38 
Methods: Herein, 149 healthy elderly Japanese subjects performed the SWT, and were 39 
assessed for height, weight, smoking history, 10-m walk time, Timed Up and Go (TUG) 40 
scores, handgrip strength, skeletal mass index (SMI), forced vital capacity (FVC), 41 
forced expiratory volume in 1 s (FEV1), cardio-ankle vascular index, and ankle brachial 42 
index. We divided men and women into higher and lower SWT score groups, compared 43 
between-group parameters, and performed stepwise multivariate logistic regression 44 
analysis to identify factors independently associated with SWT scores.  45 
Results: Age, BMI, 10-m walk time, TUG score, SMI, FVC (lit.; %-predicted), and 46 
FEV1 (lit.; %-predicted) were significantly different between SWT score groups for men, 47 
while in women, significant differences were observed in age, TUG score, handgrip 48 
strength, FVC (lit.; %-predicted), and FEV1 (lit.; %-predicted) (p < 0.05). In the 49 
multivariate logistic regression model, 10-m walk time, and FEV1 showed significant 50 
associations with SWT results in men; among women, age was the only significantly 51 
associated factor (p < 0.05). 52 
Conclusions: Results indicate that better lung function and shorter walk time 53 
independently associate with SWT results in community-dwelling men; in women, age 54 
 3 
is the only association. Our findings may offer insight when considering the focus of 55 
community exercise programs among the elderly. 56 
 57 
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In our currently aging society, it has been shown that preserving higher 62 
endurance in elderly populations increases their level of physical activity [1] and 63 
prevents frailty [2], cardiovascular disease [3], and even mortality [4]. The accepted 64 
standard for endurance evaluation is the measuring of maximum oxygen consumption 65 
(VO2 max) via treadmill. However, this requires technical equipment and the expertise 66 
of a tester, and is instituted only in laboratory or hospital settings. Thus, to preserve 67 
endurance among the community-dwelling elderly, a more straightforward and 68 
acceptable endurance assessment is required. 69 
The incremental shuttle walking test (SWT) was developed by Singh [5] to 70 
assess the endurance of patients with chronic obstructive pulmonary disease (COPD) [5] 71 
or chronic heart failure [6, 7]. The SWT required subjects to walk back and forth along 72 
a 10-m flat course, with progressive increases in pace imposed by audio signals, until 73 
the subject was no longer able to maintain the pace [5]. The SWT can yield a 74 
physiological response similar to a treadmill test [8]. Therefore, use of the SWT is 75 
pervasive as a reliable endurance assessment test. The SWT can be administered in the 76 
local community; some previous studies have demonstrated its usefulness for evaluating 77 
endurance in community-dwelling people [9-11]. Moreover, to evaluate large numbers 78 
of people in varied non-laboratory settings, the SWT is a simpler and lower-cost method 79 
than the treadmill test, which is regarded as the most precise endurance test for 80 
community-dwelling elderly.  81 
In recent years, SWT results have been shown to associate with various factors 82 
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such as age [10, 11], sex [11], body composition [10], gait parameter [7, 10, 12], lung 83 
function [13] and cardiovascular function [14]. However, the enrolled study subjects 84 
were of varied age, and presented with an array of health conditions ranging from 85 
healthy subjects to patients suffering from COPD or heart failure. For the 86 
community-dwelling elderly, investigating the determinants of SWT data may reveal 87 
what function physicians should focus on to increase endurance performance of this 88 
demographic. However, relatively few studies exist that aim to investigate SWT results 89 
in such an age group. Therefore, the aim of the present study was to determine the 90 
factors associated with SWT results in community-dwelling elderly people.  91 
 92 
Material and Methods 93 
Subjects 94 
Elderly community-dwelling subjects were recruited through local press 95 
advertising from November 11–12, 2012. A total of 149 subjects (73 men and 76 96 
women aged 74 ± 4 years) were enrolled upon having met the inclusion criteria (age ≥ 97 
65 years, able to walk independently). Exclusion criteria were using walking aids such 98 
as a cane or walker, having a medical history (or post-operative history) of severe 99 
cardiac, musculoskeletal, or pulmonary disease, and having significant hearing 100 
impairment. Demographic data including age, body mass index (BMI), and smoking 101 
history were obtained. To assess smoking history, the pack-years index [15] was 102 
calculated for each subject by multiplying the number of cigarette packs smoked per 103 
day by the number of smoking years. 104 
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Written informed consent was obtained from each subject in accordance with the 105 
guidelines of the Kyoto University Graduate School of Medicine and the 1995 106 
Declaration of Helsinki. This study protocol was approved by the ethics committee of 107 
the Kyoto University Graduate School of Medicine. 108 
 109 
SWT 110 
The SWT required subjects to walk back and forth along a 10-m flat course, with 111 
progressive increases in pace imposed by audio signals, until the subject was no longer 112 
able to maintain the pace. Up to 50 successions of the SWT were performed (500 m 113 
total walking). We divided subjects into 2 groups based on SWT scores: ≤40 or >41 114 
[16].  115 
 116 
Motor function tests 117 
All subjects were assessed using the 10-m walk test, Timed Up and Go (TUG) 118 
test, and handgrip strength test. In the 10-m walk test, subjects walk along 10-m flat 119 
pathways at a comfortable speed [17]. In the TUG test, participants were instructed to 120 
stand up from a standard chair with a seat height of 40 cm, walk a distance of 3 m at 121 
their fastest pace, turn, walk back to the chair, and sit down. The time elapsing from the 122 
verbal command to begin the task until completion was recorded with a stopwatch [18]. 123 
The 10-m walk time and TUG scores were defined as the mean time in seconds 124 
recorded at the subjects’ second trials. In the handgrip strength test, participants used a 125 
hand-held dynamometer with the arm kept to the side of the body. Participants squeezed 126 
 7 
the dynamometer with maximum isometric effort. No other body movement was 127 
allowed [19]. The handgrip test score was defined as the better performance of two 128 
trials. 129 
 130 
 Skeletal muscle mass index (SMI)  131 
A bioelectrical impedance data acquisition system (Inbody 430; Biospace Co., 132 
Ltd., Seoul, Korea) was used to determine body composition [20]. Participants were 133 
asked to stand on two metallic electrodes and hold metallic grip electrodes while the 134 
system applied a constant current of 800 mA at 50 kHz through the body. The data 135 
acquisition system calculated the resistance value and muscle mass of the respective 136 
body parts (right arm, left arm, right leg, left leg, and trunk). Appendicular skeletal 137 
muscle mass was determined using segmental body composition and muscle mass 138 
excluding the trunk; a value for the appendicular skeletal muscle mass was determined 139 
and used for the current analysis. SMI was obtained by dividing the appendicular 140 
skeletal muscle mass by the square of height (kg/m2). This index has been used and 141 
well-documented in several epidemiological studies[21].  142 
 143 
Lung function  144 
All subjects underwent spirometric evaluation. Forced vital capacity (FVC), and 145 
forced expiratory volume in 1 s (FEV1) were measured by a spirometer (Spiro Sift 146 
SP-370; Fukuda Denshi Co., Ltd., Tokyo, Japan). Next, we calculated percent predicted 147 
FVC and FEV1, corrected for height and age. Pulmonary function tests were carried out 148 
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according to the guidelines of the Japanese Respiratory Society [22]. The formulae for 149 
calculating percent predicted FVC and FEV1 were derived from Japanese criteria [23]. 150 
The FEV1/FVC ratio was also calculated. 151 
 152 
Cardiovascular function 153 
All subjects underwent cardio-ankle vascular index (CAVI) evaluation and ankle 154 
brachial index (ABI) evaluation, which were determined using the VaSera-1500 155 
(Fukuda Denshi Co., Ltd., Tokyo, Japan) as previously reported [24, 25].  156 
CAVI is a novel method for measuring arterial stiffness. Until recently, pulse 157 
wave velocity (PWV) was the most popular measure; however, PWV was dependent on 158 
blood pressure at the time of measurement. CAVI was calculated based on parameter β, 159 
independent of blood pressure [26]. Scores ≤9.00 were considered normal while scores 160 
>9.00 were considered indicative of suspected arteriosclerosis [27]. The ABI described 161 
the arterial occlusion with a ratio of the ankle to brachial systolic blood pressure [28]. 162 
Normal values 0.91 ≤ ABI ≤ 1.30 and values ≤0.90 indicated suspected peripheral artery 163 
disease (PAD) [29]. 164 
When measuring CAVI and ABI, subjects were supine and had blood pressure 165 
cuffs on both of the brachia and ankles. Measurements were taken once per subject, and 166 
mean values of the right and left CAVI and ABI scores were calculated. Using these 167 
index values, we calculated the population (%) with suspected arteriosclerosis and PAD. 168 
 169 
Statistical analyses 170 
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We analyzed the difference in each variable between men and women, and 171 
between subjects with higher and lower SWT results. We performed a Chi-squared (χ2) 172 
test to analyze the population with suspected arteriosclerosis and PAD. Moreover, 173 
statistical tests such as t-tests were also conducted to assess the influence of other 174 
variables. 175 
Next, we examined factors associated with the SWT results using a stepwise 176 
multivariate logistic regression model. We assigned the high SWT results group as a 177 
dependent variable and age, BMI, SMI, 10-m walk time, handgrip strength, FVC (lit.), 178 
FEV1 (lit.), FEV1/FVC ratio, and suspected arteriosclerosis population as explanatory 179 
variables. 180 
All statistical analyses were performed with SPSS 20.0 software (SPSS Inc., 181 




Measurements of the 149 subjects are summarized in Table 1. There were 186 
significant differences between men and women in the pack-years index, TUG score, 187 
handgrip strength, SMI, FVC (lit.), FEV1 (lit.), FEV1 (%-predicted), and suspected 188 
arteriosclerosis population (p < 0.05).  189 
Forty-two men and 26 women were classified into the higher SWT results group 190 
and 31 men and 50 women were classified into the lower SWT results group. Among 191 
men, there were significant differences between higher and lower SWT results groups in 192 
 10 
age, BMI, 10-m walk time, TUG score, SMI, FVC (lit.), FVC (%-predicted), FEV1 (lit.), 193 
and FEV1 (%-predicted) (p < 0.05). In women, there were significant differences 194 
between higher and lower SWT results groups in age, TUG score, handgrip strength, 195 
FVC (lit.), FVC (%-predicted), FEV1 (lit.), and FEV1 (%-predicted) (p < 0.05). 196 
In the multivariate logistic regression analysis, variables that remained in the 197 
final step of the regression model were considered to be significantly correlated with a 198 
higher SWT result. In men, these were 10-m walk time (p = 0.001), and FEV1 (p < 199 
0.001), whereas in women, age (p < 0.001) was the only significantly correlated 200 
variable (Table 2).  201 
 202 
Discussion 203 
We analyzed the association between SWT results and age, body composition, 204 
motor function, lung function, and cardiovascular function in community-dwelling 205 
elderly people. We found that younger age, higher FEV1, and shorter 10-m walk time 206 
were associated with higher SWT results in men, and that younger age associated with 207 
higher SWT results in women. To date, there are few studies of the relationship between 208 
lung function and SWT results in community-dwelling elderly people. The results of the 209 
present study suggest that maintaining better lung function and walk speed is the key to 210 
preserving endurance in community-dwelling elderly men.  211 
It has been previously shown that a decrease in FEV1 increases dyspnea during 212 
exercise and results in decreased walk speed and endurance in patients with airflow 213 
limitation [13, 30, 31]. We considered that in community-dwelling elderly populations, 214 
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a lower capacity for lung function would increase subjects’ dyspnea during the SWT 215 
test, resulting in decreased walk speed and SWT results. According to the American 216 
College of Chest Physicians guidelines [32], it is still unclear which lung function is 217 
improved by pulmonary rehabilitation in airflow limitation patients. Moreover, there are 218 
only a few studies that report that pulmonary rehabilitation improves lung function 219 
among community-dwelling elderly people. Therefore, we consider that pulmonary 220 
exercises, such as improving thorax and respiratory muscle mobility, and employing 221 
breathing techniques, may sustain better lung function and preserve endurance 222 
performance in this demographic. Further investigation, such as measuring dyspnea 223 
following the SWT, is needed to prove this hypothesis. In addition, we demonstrated an 224 
association between lung function and endurance exclusively among men. This may be 225 
attributed to the difference in smoking history between men and women in our study. As 226 
shown in Table 1, compared to women, men had a significantly higher pack-years index 227 
and significantly lower FEV1. Smoking is one of the strongest risk factors for 228 
respiratory disease [33]. Our results in community-dwelling elderly men indicate that 229 
smoking may decrease lung function, resulting in lower SWT results. To better 230 
understand the association between lung function and endurance in 231 
community-dwelling elderly women, further research should be conducted in another 232 
population that includes women with a history of smoking. 233 
We have shown that age associates with SWT results in women. Reports indicate 234 
that age can adversely affect a person’s cardiovascular function and endurance level [34, 235 
35]. Moreover, it is possible to separate factors that affect endurance according to 236 
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utilization theory and presentation theory [36]. Utilization theory acts on the premise 237 
that endurance is determined by the oxygen (O2)-consuming parties, while presentation 238 
theory states that it is determined by the O2-supplying party. Saltin et al. showed that 239 
endurance is more markedly affected by O2 presentation than by utilization [36]. In the 240 
present study, lung function, considered to be a presentation theory component, affected 241 
endurance performance more so than SMI, cardiovascular function, and motor function, 242 
which are components of the utilization theory. We also considered that our findings, 243 
with regard to age, may be associated with low cardiac function, which could 244 
potentially yield decreased SWT results. It would have been beneficial to additionally 245 
measure cardiovascular function parameters, such as stroke volume and pulse.  246 
There are several limitations to the scope of our research. First, because this is a 247 
cross-sectional study, the causal relationship between endurance and lung function, 248 
walk speed, or age is uncertain. Moreover, the study sample did not include women 249 
with a history of smoking. As smoking history has great impact on lung function, this 250 
may be a source of sampling bias; therefore, the scope of our investigation should be 251 
extended to subjects in other communities. Another source of study limitation is that we 252 
were unable to assess other SWT-affecting factors, although these may indeed affect 253 
SWT results. In addition to cardiovascular function and dyspnea factors, previous 254 
studies have shown that step length can affect SWT or 6 min walk test results [7, 37]. 255 
Thus, further analysis should be undertaken to identify additional factors that may be of 256 
importance to endurance performance.  257 
 258 
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Conclusion  259 
We found a significant association between lung function, walk speed, and SWT 260 
results in community-dwelling elderly men, and between age and SWT results in 261 
women. In this society, prevention for bedridden and taking care is an important issue in 262 
terms of medical economics. Elderly men with a high level of expiratory function 263 
display high endurance performance. Although this is a cross-sectional study, our results 264 
may help advise physicians of ways in which they can promote endurance performance 265 
among the elderly, through focusing and adapting community exercise programs. 266 
However, further investigation is required to assess the impact of cardiovascular 267 
function on SWT results in community-dwelling elderly populations. 268 
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Table 1. Comparison of demographic characteristics and measurements 390 








(n = 42) 
Lower level 
SWT  






level SWT  
(n = 26) 
Lower level 
SWT  
(n = 50) 
p-value*   
p-value
** 
General characteristics         
  
    
 
Age, years (SD)† 73.7 (4.6) 
72.3 
(4.1) 
75.6 (4.7) 0.002 73.4 
(4.3) 
70.2 (3.5) 75.1 (3.7) <0.001   0.71 
BMI, kg/m2 (SD)† 23.4 (3.1) 
24.1 
(3.0) 
22.6 (3.1) 0.048 23.3 
(2.7) 







29.9 (24.6) 0.81 0 (0) 0 (0) 0 (0) -   <0.001 
          
  
    
 
Motor function         
  
    
 
10-m walk time, s 
(SD)† 
7.3 (1.0) 
6.9 (0.7) 7.8 (1.1) <0.001 7.3 
(1.3) 
6.9 (0.8) 7.5 (1.5) 0.06   0.81 
TUG, s (SD)† 6.4 (1.1) 
6.1 (0.9) 7.0 (1.0) <0.001 6.9 
(1.1) 
6.4 (0.8) 7.2 (1.1) 0.004   0.008 
Handgrip strength, kg 33.4 (5.9) 34.4 32.4 (5.9) 0.09 23.0 24.3 (3.1) 22.3 (3.9) 0.02   <0.001 
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(SD)† (5.8) (3.8) 
 
        
  
    
 
Body composition         
  
    
 
SMI, kg/m2 (SD)† 7.3 (0.7) 
7.5 (0.7) 7.0 (0.6) 0.01 5.8 
(0.6) 
6.0 (0.6) 5.7 (0.5) 0.02   <0.001 
          
  





    
  
  
    
 
FVC, lit. (SD)† 3.2 (0.6) 
3.4 (0.5) 3.0 (0.4) <0.001 2.2 
(0.5) 












94.0 (15.1) 0.01   0.56 
FEV1, lit. (SD)† 2.3 (0.6) 
2.5 (0.5) 2.0 (0.5) <0.001 1.6 
(0.5) 












92.4 (20.3) 0.01   0.007 





68.8 (12.1) 0.11 
72.6 
(11.2) 
75.5 (11.9) 71.1 (10.6) 0.10   0.39 
          
  





    
  
  





72.6 71.4 74.2 0.79 48.6 34.6 56.0 0.08   0.003 
Suspected PAD, % †† 5.5 0 0 - 1.3 0 2.0 0.47   0.56 
           Note: BMI, body mass index; TUG, Timed Up and Go; SMI, skeletal mass index; FVC, forced vital capacity; FEV1, 
forced expiratory volume in 1 s; PAD, peripheral artery disease.    
†: t-test, ††: χ2-test 
          
*: comparison between higher and lower level of SWT 
**: comparison between men and women        
 21 
Table 2. Multivariate logistic regression model with stepwise selection to determine 391 
the association with shuttle walking test level 392 
  Odds ratio 95% CI p-value 
Men 
   10-m walk time (s)  0.24 0.11–0.54 0.001* 
FEV1 (lit.) 12.80 3.05–53.70 0.001* 
  
   Women 
   Age 0.69 0.57–0.82 < 0.001** 
*: p < 0.05, **: p < 0.001 
 Note: CI, confidence interval; FEV1, forced expiratory volume in 1 s. 
 393 
 394 
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